January 17, 2024Open Access

Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

In this prospective, randomized clinical trial, SsK12 probiotic significantly reduced the incidence, onset, and duration of SOM with a good safety profile.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Peng et al. (Wed,) studied this question.

synapsesocial.com/papers/69d9e2c95e5bcb4e3b8382f2 https://doi.org/https://doi.org/10.1200/jco.23.00837

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study2011 · 178 citations
2Selenomonas sputigena Interactions with Gingival Epithelial Cells That Promote Inflammation2023 · 29 citations
3Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines2020 · 113 citations
4New thoughts on the initiation of mucositis2010 · 187 citations
5The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic2014 · 9,085 citations

Me gusta

Guardar

Ver artículo completo